Almitas Capital’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.27M Buy
506,395
+353,481
+231% +$5.25M 1.64% 12
2025
Q4
$2.3M Buy
+152,914
New +$2.3M 0.51% 40
2025
Q2
Sell
-204,834
Closed -$3.05M 84
2025
Q1
$3.05M Sell
204,834
-1,134,764
-85% -$17.8M 1.01% 17
2024
Q4
$19.3M Sell
1,339,598
-164,795
-11% -$2.55M 4.23% 5
2024
Q3
$23.8M Sell
1,504,393
-257,550
-15% -$4.06M 8.42% 2
2024
Q2
$27.1M Buy
1,761,943
+831,025
+89% +$12.6M 11.25% 1
2024
Q1
$15.3M Sell
930,918
-362,293
-28% -$5.71M 6.3% 3
2023
Q4
$18.9M Buy
1,293,211
+1,189,017
+1,141% +$16.6M 6.53% 2
2023
Q3
$1.5M Buy
+104,194
New +$1.62M 0.72% 37

Other funds holding BMEZ

Almitas Capital's BMEZ Position: Q1 2026 in Review

Almitas Capital increased its BlackRock Health Sciences Trust II (BMEZ) stake by 231% in Q1 2026, buying an estimated $5.25M and bringing the position to 506,395 shares worth $7.27M. The position accounts for 1.64% of the portfolio, ranked #12.

Almitas Capital first reported a position in BMEZ in Q3 2023 and has held it in 9 quarters since. The position peaked at $27.1M in Q2 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Almitas Capital held 506,395 shares of BlackRock Health Sciences Trust II worth $7.27M as of Q1 2026.
  • Almitas Capital bought 353,481 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $5.25M.
  • BlackRock Health Sciences Trust II made up 1.64% of Almitas Capital's portfolio in Q1 2026, its #12 holding.
  • Almitas Capital first reported a position in BlackRock Health Sciences Trust II in Q3 2023 and has held it in 9 quarters since.
  • Almitas Capital's BlackRock Health Sciences Trust II position peaked at $27.1M in Q2 2024.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Almitas Capital's 13F filing for Q1 2026, filed 15 May 2026.